Lanreotide T20534
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Lanreotide, a somatostatin analogue, suppresses GH/IGF-I hypersecretion in acromegaly patients. It also used to manage neuroendocrine tumours.
CAS nr:
108736-35-2
Purity:
98%
Molecular Weight:
1096,33
SMILES:
CC([C@@H]1NC([C@@H](NC([C@H](NC([C@@H](NC([C@@H](NC([C@@H](Cc(cc2)cc3c2cccc3)N)=O)CSSC[C@@H](C(N[C@H](C(N)=O)[C@H](O)C)=O)NC1=O)=O)Cc4ccc(O)cc4)=O)Cc(c[nH]5)c6c5cccc6)=O)CCCCN)=O)C
Formula:
C54H69N11O10S2
Pathway:
Target:
